Cargando…
Coding long COVID: characterizing a new disease through an ICD-10 lens
BACKGROUND: Naming a newly discovered disease is a difficult process; in the context of the COVID-19 pandemic and the existence of post-acute sequelae of SARS-CoV-2 infection (PASC), which includes long COVID, it has proven especially challenging. Disease definitions and assignment of a diagnosis co...
Autores principales: | Pfaff, Emily R., Madlock-Brown, Charisse, Baratta, John M., Bhatia, Abhishek, Davis, Hannah, Girvin, Andrew, Hill, Elaine, Kelly, Elizabeth, Kostka, Kristin, Loomba, Johanna, McMurry, Julie A., Wong, Rachel, Bennett, Tellen D., Moffitt, Richard, Chute, Christopher G., Haendel, Melissa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9931566/ https://www.ncbi.nlm.nih.gov/pubmed/36793086 http://dx.doi.org/10.1186/s12916-023-02737-6 |
Ejemplares similares
-
Coding Long COVID: Characterizing a new disease through an ICD-10 lens
por: Pfaff, Emily R, et al.
Publicado: (2022) -
Risk Factors Associated with Post-Acute Sequelae of SARS-CoV-2 in an EHR Cohort: A National COVID Cohort Collaborative (N3C) Analysis as part of the NIH RECOVER program
por: Hill, Elaine, et al.
Publicado: (2022) -
Identifying who has long COVID in the USA: a machine learning approach using N3C data
por: Pfaff, Emily R, et al.
Publicado: (2022) -
Risk factors associated with post-acute sequelae of SARS-CoV-2: an N3C and NIH RECOVER study
por: Hill, Elaine L., et al.
Publicado: (2023) -
Effect of Nirmatrelvir/Ritonavir (Paxlovid) on Hospitalization among Adults with COVID-19: an EHR-based Target Trial Emulation from N3C
por: Bhatia, Abhishek, et al.
Publicado: (2023)